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BACKGROUND: Paper spray mass spectrometry6 is a tech-
nique that has recently emerged and has shown excellent
analytical sensitivity to a number of drugs in blood. As an
alternative to blood, fingerprints have been shown to
provide a noninvasive and traceable sampling matrix.
Our goal was to validate the use of fingerprint samples to
detect cocaine use.
METHODS: Samples were collected on triangular pieces
(168 mm2) of washed Whatman Grade I chromatogra-
phy paper. Following application of internal standard,
spray solvent and a voltage were applied to the paper
before mass spectrometry detection. A fingerprint visual-
ization step was incorporated into the analysis procedure
by addition of silver nitrate solution and exposing the
sample to ultraviolet light.
RESULTS: Limits of detection for cocaine, benzoylecgo-
nine, and methylecgonine were 1, 2, and 31 ng/mL re-
spectively, with relative standard deviations 33%. No
matrix effects were observed. Analysis of 239 fingerprint
samples yielded a 99% true-positive rate and a 2.5%
false-positive rate, based on the detection of cocaine,
benzoylecgonine, or methylecgonine with use of a sin-
gle fingerprint.
CONCLUSIONS: The method offers a qualitative and non-
invasive screening test for cocaine use. The analysis
method developed is rapid (4 min/sample) and requires
no sample preparation.
© 2017 American Association for Clinical Chemistry
Drug testing is carried out by an increasing number of
entities, including courts, probation services, prisons,
work places, and drug rehabilitation clinics (1–3 ). To
demonstrate use of an illicit substance, normally either a
blood or urine sample is collected. Neither matrix is
quick to collect, and the samples are biohazardous and
must be stored and transported accordingly (4 ). In con-
trast, a (latent) fingerprint is easy to collect and, most
importantly, the ridge detail of the fingerprint assures
traceability of the sample and chain of custody.
Recent publications have demonstrated the poten-
tial for detecting drugs and metabolites from fingertips.
Approaches have included detection using spectroscopy
(5–8 ), antibodies (9–12), and mass spectrometry (13–
18). Spectroscopic- and antibody-based detection of
drugs in fingerprints offers limited analytical selectivity
compared with mass spectrometry. Methadone (15 ) and
lorazepam (16 ) can be detected in fingerprints by use of
LC-MS. However, these methods require lengthy sam-
ple preparation, and therefore any commercialized test
would be expensive to carry out due to the low
throughput. These methods also do not offer the pos-
sibility for visualizing the fingerprint after collection,
therefore missing a key advantage (i.e., traceability) of
fingerprint-based drug detection.
Recently, desorption electrospray ionization (14) and
MALDI (19–21) mass spectrometry techniques have
been proposed for fingerprint chemical analysis. These
techniques offer the advantages that the sample can be
rapidly analyzed (approximately 2 min) and that the fin-
gerprint ridge detail can be recorded before analysis to
ensure traceability. However, limitations of these tech-
niques include the cost of acquiring the ionization source
and difficulty in obtaining quantitative data (22 ).
Liquid extraction surface analysis (13 ) can also be
used to detect cocaine and its metabolites in fingerprints.
This technique has the drawbacks of a relatively expen-
sive instrument cost and a slightly lower throughput than
MALDI or desorption electrospray ionization.
Paper spray mass spectrometry (PS-MS) is a tech-
nique that has recently emerged (23, 24 ) and is steadily
gaining popularity, most likely due to the low setup cost
(our home-built system cost approximately $50 to build)
and the excellent analytical sensitivity. A commercial sys-
1 Ion Beam Centre, University of Surrey, Surrey, UK; 2 University of Surrey, Department of
Chemistry, Surrey, UK; 3 Netherlands Forensic Institute, the Hague, the Netherlands;
4 Department of Chemical Engineering, Delft University of Technology, Delft, the Neth-
erlands; 5 Intelligent Fingerprinting, Cambridge, UK.
* Address correspondence to this author at: Ion Beam Centre, University of Surrey, GU2
7XH, Guildford, Surrey, UK. E-mail c.d.costa@surrey.ac.uk.
Received May 10, 2017; accepted August 9, 2017.
Previously published online at DOI: 10.1373/clinchem.2017.275578
© 2017 American Association for Clinical Chemistry
6 Nonstandard abbreviations: PS-MS, paper spray mass spectrometry; BZE, benzoylecgo-
nine; EME, ecgonine methyl ester; ACN, acetonitrile; PS, paper spray; A/IS, analyte-to-
internal standard ratio.
Clinical Chemistry 63:11
000–000 (2017)
Drug Monitoring and Toxicology
1
AQ: A
Fn6
AQ: G
AQ: H
AQ: I
AQ: G
AQ: H
AQ: I
AQ: G
AQ: H
AQ: I
rich3/zcy-clnchm/zcy-clnchm/zcy01117/zcy2398d17z xppws S=1 9/12/17 11:33 4/Color Figure(s): F4 Art: 275578 Input-1st disk, 2nd
tem is now available, designed specifically for dried blood
spot analysis (25–27), and the technique has shown ex-
cellent analytical sensitivity for a number of drugs in
blood (25 ). The substrate used in commercial PS-MS
systems is too small (typically dimensions of 8 mm2 are
used) to effectively sample a latent fingerprint. Here we
report on an adaptation of the PS-MS technique, using
triangles of 168 mm2 area and applied as a rapid screen-
ing test for cocaine use by use of fingerprint samples. The
method developed was applied to fingerprint samples
collected from drug users as well as nondrug users to
evaluate its efficacy. Finally, we tested the feasibility of
using this method together with a development pro-
cess to capture the ridge detail of the fingerprint before
analysis.
Materials and Methods
MATERIALS
Drug standards [cocaine, benzoylegonine (BZE), ecgonine
methyl ester (EME), cocaine-D3, BZE-D3, and EME-D3]
were prepared fromcertified referencematerials (Cerilliant).
LC-MS–grade solvents [methanol, acetonitrile (ACN), and
water] were used to prepare all solutions and solvent mix-
tures (Fischer Scientific). Formic acid (Fischer Scientific)
was added to every spray solvent at 0.1% v/v. Silver nitrate
stock solution (0.1 mol/L) was bought from Sigma Aldrich
and diluted with deionized water (18 mol/LDI water) as
required for the experiments. Artificial perspirationwas pur-
chased from Pickering Laboratories.
SAMPLE COLLECTION
Fingerprint and oral fluid samples were collected from 16
individuals seeking treatment at drug rehabilitation clin-
ics. A favorable ethical opinion for collection and analysis
of samples was received from the National Research Eth-
ics Service (reference: 14/LO/0346). Oral fluid samples
were collected using a QuantisalTM (AlereTM) collection
device. Analysis of the oral fluid samples was carried out
at Claritest. Screening by Claritest used immunoassay
testing followed by LC-MS/MS quantification if the
screening result was positive. For fingerprint sample col-
lection, the collection kit consisted of chromatography
paper (Whatman Grade 1) cut into a “house-shape” that
was comprised of a triangular area of dimensions 1.6 
2.1 cm (base  height) and a rectangular extension that
was used to tape the substrate to a glass slide (see Fig. 1 in
the Data Supplement that accompanies the online ver-
sion of this article at http://www.clinchem.org/content/
vol63/issue11). The fingerprint sample was collected on
the triangular area of the substrate, which was then re-
moved for analysis. Fingerprint and oral fluid samples
were collected from the 16 participants (10 fingerprints
from each) using 3 different collection procedures. The
first procedure—“wipes” (Participants 1–4)—comprised
wiping the fingertips using alcohol-free wipes (Steroplast®)
while wearing nitrile gloves for 10 min, touching the face
(grooming), rubbing the fingertips together, and depositing
the samples. For the second collection procedure—“soap”
(Participants 5–7)—participants were asked to wash their
hands with soap and follow the same procedure as above.
Finally, the third collectionprocedure—“ungroomedwipe”
(Participants 8–12)—was exactly the same as the wipe
method, but participants did not touch the face before de-
positing the fingerprint sample (to avoid picking up analytes
from the face and reduce the oil content in the sample).
Samples were collected by use of kitchen scales (Sainsbury’s
Color) to measure the pressure applied during collection
(800–1200 g for 10 s).
To observe the background concentrations of co-
caine, BZE, and EME in the general population, finger-
print samples were collected from 40 participants not
known to be drug users. Fingertips were wiped with
alcohol-free wipes, and gloves were worn for 10 min to
induce sweating. Samples were collected using the same
collection kit described earlier (see Fig. 1 in the online
Data Supplement) with 800–1200 g of pressure (mea-
sured with kitchen scales). Two samples—right index
and right middle fingers—were collected from each par-
ticipant (total of 80 samples). Therefore, a total of 240
fingerprint samples (80 from nondrug users; 120 and 40
from drug users with and without development, respec-
tively) were collected. One sample failed to spray, giving
a total of 239 samples successfully analyzed.
INVESTIGATION OF MATRIX EFFECTS
Artificial eccrine perspiration was used to optimize the
paper spray (PS) source parameters because it was thought
to represent the fingerprint matrix. To investigate the
matrix effects of artificial perspiration vs fingerprints,
standards of cocaine, BZE, and EME (50 ng/mL) were
prepared in artificial perspiration or acetonitrile. To test
the matrix effects of real fingerprints, 5 overlaid finger-
prints (to provide an unrealistically high mass of matrix
material) and 1 single fingerprint (to provide a more rep-
resentative mass of matrix) from a single female partici-
pant were deposited on substrates before the addition of
the analyte standard dissolved in acetonitrile.
PS ANALYSIS
The PS source was designed and built at the University of
Surrey and was coupled with a Micromass QToF 2 mass
spectrometer (Waters Alliance). Data processing of all
spectra was performed by use of MassLynx 4.1 (28 ). The
cone voltage (25 V) and extraction voltage (5 V) were
optimized by use of electrospray ionization by selecting
the conditions that gave the highest yield of the proton-
ated ions corresponding to the analytes—cocaine (m/z
304.15), BZE (m/z 290.14), and EME (m/z 200.13).
The optimized collision energies for detection of frag-
2 Clinical Chemistry 63:11 (2017)
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ment ions corresponding to cocaine (m/z 304  182),
BZE (m/z 290 168), and EME (m/z 200 182) were
set at 21, 19, and 21 eV, respectively.
The PS analysis method was optimized as detailed
below. The paper substrate consisted ofWhatman Grade
1 chromatographic paper cut into a triangular shape (1.6
cm base, 2.1 cm height). Precut paper was submitted to a
wash procedure consisting of 0.1%hydrochloric acid and
50:50 (% v/v) methanol:water and allowed to air dry
before analysis.
The optimized PS-MS method, adopted in all fol-
lowing experiments (see Fig. 2 in the online Data Sup-
plement), included the following steps. First, the sample
(either a fingerprint or standard) was loaded onto the
paper followed by deposition of the internal standard (20
L of 50 ng/mL cocaine-D3, BZE-D3, and EME-D3).
The loaded paper was then allowed to air dry (5 min),
before being placed in the source on top of a glass slide
and below a folded piece of aluminum foil designed to
minimize carryover effects (preventing direct contact be-
tween the high voltage clip and the sample). The tip of
the paper was positioned perpendicular to the mass spec-
trometer inlet cone at a distance of 2 3mm (x y) (see
Fig. 3 in the online Data Supplement). A spray solvent
[80:20 (%v/v) ACN:water] was then pipetted (100 L)
onto the paper and voltage applied (4.0 kV). Data was
acquired for 2 min in full scan mode (m/z 50–500) for
quantitative measurements, after which the voltage was
turned off. Finally, another 100 L of spray solvent was
added to the paper and the voltage restarted for another 2
min for peak qualification using MS/MS.
SILVER NITRATE DEVELOPMENT
To demonstrate the efficacy of retaining fingerprint ridge
detail while also providing chemical analysis, silver ni-
trate was used to develop fingerprints on chromatogra-
phy paper. This was then applied to a selection of finger-
print samples collected from individuals at the drug
rehabilitation center. Before sample collection, silver ni-
trate was pipetted onto the paper on the fingerprint col-
lection kits: 40 L of 25 mmol/L silver nitrate was pi-
petted onto 10 kits and 60L of 15mmol/L silver nitrate
were pipetted onto another 10 kits. Samples were allowed
to dry before being placed in a storage box for transport to
the clinic. Fingerprint samples were collected from 4 par-
ticipants (Participants 13–16), in which fingerprints
from one hand were collected on a substrate treated with
silver nitrate and fingerprints from the other hand were
collected on the untreated paper substrate (control sam-
ples). Fingerprint samples were collected with a pressure
of 100–200 g. Samples were transported to the labora-
tory where they were exposed to ultraviolet light (254
nm) for 5 min.
Results and Discussion
INVESTIGATION OF MATRIX EFFECTS
Fig. 4 in the online Data Supplement shows the mean
(n 3) measured peak intensities for cocaine, BZE, and
EME in the presence of artificial perspiration, acetoni-
trile only, and 5 or 1 fingerprint samples. The signal
intensities for artificial perspiration were approximately
2-fold lower than with acetonitrile, implying ionization
suppression. In contrast, with the exception of EME,
which showed a small difference between acetonitrile and
5 or 1 fingerprints, no substantial difference in signal
intensity was observed in the presence of either 5 or 1
fingerprints compared to acetonitrile only for cocaine or
BZE. Therefore, no analytically important matrix effects
of the fingerprints were observed. Furthermore, the re-
sults demonstrated that artificial perspiration was not a
good representation of the fingerprint matrix.
METHOD PERFORMANCE
The PS method (Fig. 2 in the online Data Supplement)
was applied to calibrators containing cocaine, BZE, and
EME (20 L, prepared in 100% ACN) in the 0–500
ng/mL range. Fig. 1 shows the calibration curves for,
cocaine (Fig. 1A), BZE (Fig. 1B), and EME (Fig. 1C)
plotted as the analyte-to-internal standard ratio (A/IS).
The peak assignments in full scan mode were confirmed
by the MS/MS measurements.
The method yielded relative standard deviations be-
tween 3%–33%, depending on the analyte and concen-
tration (Table 1 in the online Data Supplement). The
resulting correlation factors (R2) were poorer than previ-
ously reported for PS-MS, which could be explained by
the fact that for previous work on dried blood spot anal-
ysis the internal standard was mixed into the sample be-
fore being spotted on to the paper. In contrast, for fin-
gerprint analysis, the fingerprint must first be applied to
the paper before addition of the internal standard. For
the calibration curves shown here, the calibrator was
added separately from the internal standard tomimic real
samples. This inevitably led to an unequal spatial distri-
bution of fingerprint and internal standard on the paper
and therefore increased variability.
The limits of detection (blank 3SD) and quanti-
fication (blank 10SD) were calculated (Table 1 in the
online Data Supplement). The calculated limits of detec-
tion (1, 2, and 31 ng/mL for cocaine, BZE, and EME,
respectively) were inferior to the PS method for the de-
tection of cocaine in dried blood spots (25 ) of 0.05
ng/mL. The difference in detection limits can be attrib-
uted partly to the difference in mass spectrometers used
(quadruple-time-of-flight mass spectrometers generally
exhibit inferior analytical sensitivity to a triple quadru-
pole in the multiple reaction monitoring mode) and also
to the separate addition of analytes and internal standard,
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as mentioned above. Example cutoffs currently used for
oral fluid testing (on the basis of BZE and cocaine) are
approximately 8 ng/mL. Of course, a cutoff for finger-
print testing has not yet been established, but assuming
an equal relationship between fingerprint and oral
fluid concentration of drugs and metabolites, the
method proposed here would be within industry cut-
offs and likely better than previous publications on
drugs in fingerprints.
ANALYSIS OF FINGERPRINT SAMPLES
The developed PS method was applied to fingerprint
samples collected from individuals who reported taking
cocaine in the last 24 h. Detection of EME, BZE, and
cocaine was confirmed if the relevant fragment ion was
detected above 3 counts above the background in the
MS/MS scans, consistent with previous mass spectral in-
terpretation (29 ). Example MS/MS spectra are shown in
Fig. 5 in the online Data Supplement.
Table 1 shows the detection rate for each analyte (10
fingerprints from 12 participants). The corresponding
oral fluid confirmation results are also provided. Of the
120 fingerprints, 1 fingerprint (Participant 7) could not
be analyzed due to a failed spray, resulting from the dif-
ficulty in consistently cutting a paper triangle with a
sharp tip. Table 2 shows the detection rate for 4 further
participants. The presence of at least one of the analytes -
cocaine, BZE, or EME - was confirmed in 157 samples
(98.7%) of the 159 fingerprint samples successfully
analyzed.
There was a clear discrepancy for Participant 7
between oral fluid and fingerprint test results (Table
1). While the oral fluid tested negative for cocaine, the
patient testified taking cocaine within the last 24 h, in
agreement with the fingerprint results (9/9 positive).
While the patient’s testimony has not been verified,
this observation implies a difference in detection win-
dow between fingerprints and oral fluid, which should
be explored in further studies. Indeed, the United Na-
tions Office on Drug and Crime has reported that the
detection window for sweat is longer than for oral
fluid, consistent with these observations (30 ).
Fig. 2 shows the A/IS ratio of cocaine and BZE
detected per fingerprint across the 10 fingerprint samples
for Participants 2 and 3. A number of interesting obser-
vations resulted from these data. First, the variability in
cocaine and BZE seen within a set of fingerprints was
high, and this was expected because the contact area and
positioning of fingers on the paper was not controlled.
Other studies (15 ) have shown similar levels of variability
for other substances even when fingerprint deposition
was carefully controlled.
Second, different concentrations of cocaine were ob-
served in the corresponding oral fluid samples for Partic-
ipants 2 and 3 (64 ng/mL and 8.2 ng/mL, respec-
tively). In Fig. 2, the A/IS ratio for cocaine was
Fig. 1. Calibration curves for cocaine (A), BZE (B), and EME (C).
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systematically higher in all 10 of Participant 2’s finger-
print samples, in agreement with the oral fluid results. In
contrast, the A/IS ratio for BZE did not systematically
show the much higher concentrations in Participant 2
than in Participant 3, highlighting the potential difficulty
in correlating oral fluid and fingerprint measurements in
a quantitative manner.
Fig. 3 displays the mean ratios of A/IS ratio for co-
caine measured from the thumb and index fingers (n 
4) samples collected from Participants 1–12 by use of the
different collection procedures described previously. For
the patients collected using the wipes method, a lower
signal for cocaine was seen in the fingerprints from Par-
ticipant 3 (with corresponding oral fluid of 8 ng/mL)
than in those from Participants 1 and 2 (with oral fluid
64 ng/mL), showing the possibility for distinguishing
between high and low cocaine concentrations. Compar-
ing Participant 5 with Participants 1, 2, 4, and 8–12 (all
with oral fluid  64 ng/mL), showed that washing the
hands with soap before deposition resulted in a lower
signal for cocaine, possibly due to the removal of residue
left on the hands after cocaine use, which the wiping
method failed to completely remove. The results pre-
sented here show that cocaine and metabolites are readily
detected in fingerprints after either washing hands with
soap (soap method), wiping the fingertips (ungroomed
wipes), or touching the face (wipes) to collect oily resi-
dues. Any quantitative difference arising from the finger-
print collection procedure could not be evaluated because
no validated procedure exists for collecting replicate
fingerprints.
To observe the background levels of cocaine, BZE,
and EME in the general population, fingerprint samples
were collected from 40 participants not known to be drug
Table 1. Oral ﬂuid results and ﬁngerprint detection rate (number of ﬁngerprints positive) for cocaine, BZE, and EME obtained
for participants 1 to 12, analyzed by use of paper spray mass spectrometry.
Oral ﬂuid results Cocaine, BZE, and EME
(at least one of the three)
detected in how many ﬁngerprints?Cocaine, ng/mL BZE, ng/mL
Wipes
Participant 1 >64.0 >64.0 10/10
Participant 2 >64.0 >64.0 10/10
Participant 3 8.2 >64.0 10/10
Participant 4 >64.0 >64.0 10/10
Soap
Participant 5 >64.0 >64.0 9/10
Participant 6 12 30.0 10/10
Participant 7 Negative Negative 9/9
Ungroomed wipes
Participant 8 >64.0 >64.0 10/10
Participant 9 >64.0 >64.0 10/10
Participant 10 >64.0 >64.0 10/10
Participant 11 >64.0 >64.0 10/10
Participant 12 >64.0 >64.0 10/10
Table 2. Oral ﬂuid conﬁrmatory results and ﬁngerprint detection rate obtained for participants 13–16, analyzed
with paper spray.
Oral ﬂuid results Cocaine, BZE, and EME
(at least one of the three)
detected in how many ﬁngerprints?Cocaine, ng/mL BZE, ng/mL
Participant 13 >64.0 >64.0 10/10
Participant 14 >64.0 >64.0 9/10
Participant 15 40.3 >64.0 10/10
Participant 16 Negative (5.77) >64.0 10/10
Drug Testing Using Fingerprint Development
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users. Fragment ions relating to cocaine and EME were
detected in MS/MS mode in 2 fingerprints (one each
from 2 different participants) of the 80 samples analyzed.
The origin of these 2 substances could not be confirmed
as only one of the 2 samples collected from the 2 partici-
pants tested positive, and no oral fluid sample was col-
lected from the participants. However, this could be the
result of environmental exposure that could not be re-
moved by the cleaning procedure. BZE was not detected
in any of the samples.
A drug screening protocol that returns a positive
result based on the detection of cocaine, BZE, or EME in
a single fingerprint was applied to the data. Using this
acceptance criterion, 98.7% of the patient fingerprint
samples analyzed (n  159) tested positive. Similarly,
2.5% of the background population samples (n  80)
gave a false-positive result (the 2 samples mentioned
in the previous paragraph). By instead requesting 2
fingerprints—e.g., right thumb and index—and re-
quiring both samples to be positive, a 94% true-
positive and 0% false-positive rate would be obtained
(on the basis of the right index and middle fingers
only, using the data from 16 patients and 40 nondrug
users). Therefore, despite the variability observed in
the concentration of analytes present in the finger-
prints, there is a clear discrimination between positive
and negative participants.
SILVER NITRATE DEVELOPMENT
One of the key advantages of using a latent fingerprint for
drug detection is the ability to provide a traceable sample.
Two different concentrations of silver nitrate (15
mmol/L and 25 mmol/L) were tested for their ability to
detect fingerprints on the PS paper. An ultraviolet (254
nm) light source was used to develop fingerprints. Fig. 4
shows how application of silver nitrate to the paper en-
abled the visualization of fingerprint ridge detail. The
higher concentration of silver nitrate resulted in the clear-
est ridge patterns (Fig. 4, A and B). The lower concen-
tration of silver nitrate only allowed the visualization of
fingerprints collected from Participant 16 (Fig. 4D). No
ridge detail was visible for Participant 15 (Fig. 4C). In
this case, the level of fingerprint ridge detail was not
sufficient to be used for identification purposes, but it
could be used to verify the presence of the sample on the
collection kit.
Fig. 6 in the onlineData Supplement shows the peak
intensity of cocaine, BZE, and EME detected in stan-
dards of concentration 50 ng/mL (internal standards at
50 ng/mL) analyzed with PS-MS. The peak intensity for
all 3 analytes was lower when silver nitrate was present,
suggesting that the addition of silver nitrate to the PS
work flow affects the analytical sensitivity of the method.
Nonetheless, cocaine, BZE, and EME could be identified
in fingerprints from patients through MS/MS scans (Ta-
ble 2). Out of the 20 samples developed with silver ni-
trate, 20 tested positive for cocaine, demonstrating the
viability of the procedure.
Fig. 2. Analyte-to-internal standard ratio (A/IS) measured for cocaine and BZE in ﬁngerprint samples collected from individuals
seeking treatment at a drug rehabilitation center (Participants 2 and 3).
Fig. 3. Mean analyte-to-internal standard ratio (A/IS) for co-
caine measured from the thumb and index ﬁngers (n = 4)
collected from Participants 1–12 and analyzed using paper
spray mass spectrometry.
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In summary, we have demonstrated the adaptation
of PS-MS for the detection of cocaine, BZE, and EME in
fingerprint samples. The method was applied to a total of
239 fingerprint samples, yielding a 98.7% detection rate
and a 2.5% false-positive rate based on a single finger-
print. There was some capacity to discriminate quantita-
tively between the fingerprints of participants in the
method presented here. We also showed the compatibil-
ity of the method with fingerprint development before
analysis using silver nitrate, to allow a sample to be iden-
tified from its ridge characteristics.
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Fig. 4. Example of silver-nitrate-developedﬁngerprints collected from individuals seeking treatment at a drug rehabilitation clinic
by use of 40 μL of 25 mmol/L (A, B) and 60 μL of 15 mmol/L, developed under ultraviolet light (254 nm) for 5 min.
Example MS/MS spectrum obtained from the analysis of a silver-nitrate-developed ﬁngerprint sample (Participant 14, right thumb).
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